The document is a financial research report by Morgan Stanley on Biogen Idec Inc., providing an analysis of the company's earnings, product growth, and financial projections. It includes stock ratings, industry views, and detailed financial tables such as income statements, balance sheets, and cash flow statements. The report highlights the performance of Biogen's products like Tecfidera, Tysabri, and Avonex, and discusses the company's market position and future growth prospects.
documents/EFTA01199408.pdf
{}